Ignite Creation Date:
2024-05-06 @ 10:08 AM
Last Modification Date:
2024-10-26 @ 12:25 PM
Study NCT ID:
NCT03172208
Status:
COMPLETED
Last Update Posted:
2017-11-14
First Post:
2017-05-29
Brief Title:
Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects
Sponsor:
Ablynx a Sanofi company
Organization:
Ablynx a Sanofi company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Healthy Volunteers |
Keywords: